These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 15047380)

  • 1. Polymeric contrast agent with targeting potential.
    Lathia JD; Leodore L; Wheatley MA
    Ultrasonics; 2004 Apr; 42(1-9):763-8. PubMed ID: 15047380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymeric ultrasound contrast agents targeted to integrins: importance of process methods and surface density of ligands.
    Wheatley MA; Lathia JD; Oum KL
    Biomacromolecules; 2007 Feb; 8(2):516-22. PubMed ID: 17291076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arg-Gly-Asp (RGD) peptide conjugated poly(lactic acid)-poly(ethylene oxide) micelle for targeted drug delivery.
    Hu Z; Luo F; Pan Y; Hou C; Ren L; Chen J; Wang J; Zhang Y
    J Biomed Mater Res A; 2008 Jun; 85(3):797-807. PubMed ID: 17896765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-modal detection of colon malignancy by NIR-tagged recognition polymers and ultrasound contrast agents.
    Bloch M; Jablonowski L; Yavin E; Moradov D; Djavsarov I; Nyska A; Wheatley M; Rubinstein A
    Int J Pharm; 2015 Jan; 478(2):504-16. PubMed ID: 25437110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound degradation of novel polymer contrast agents.
    El-Sherif DM; Lathia JD; Le NT; Wheatley MA
    J Biomed Mater Res A; 2004 Jan; 68(1):71-8. PubMed ID: 14661251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable nanoparticles for targeted ultrasound imaging of breast cancer cells in vitro.
    Liu J; Li J; Rosol TJ; Pan X; Voorhees JL
    Phys Med Biol; 2007 Aug; 52(16):4739-47. PubMed ID: 17671332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodegradable poly (lactic acid) microspheres for drug delivery systems.
    Hyon SH
    Yonsei Med J; 2000 Dec; 41(6):720-34. PubMed ID: 11204823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved double emulsion technology for fabricating autofluorescent microcapsules as novel ultrasonic/fluorescent dual-modality contrast agents.
    Gong A; Ma X; Xiang L; Ren W; Shen Z; Wu A
    Colloids Surf B Biointerfaces; 2014 Apr; 116():561-7. PubMed ID: 24583258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate-loaded PLGA nanobubbles for ultrasound imaging and Synergistic Targeted therapy of residual tumor during HIFU ablation.
    Zhang X; Zheng Y; Wang Z; Huang S; Chen Y; Jiang W; Zhang H; Ding M; Li Q; Xiao X; Luo X; Wang Z; Qi H
    Biomaterials; 2014 Jun; 35(19):5148-61. PubMed ID: 24680663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro assessment of the dual-targeting behavior of a peptide-based magnetic resonance imaging contrast agent.
    Yang Y; Yu K; Zhang H; Dai J; Deng Z
    Int J Mol Med; 2014 Jan; 33(1):215-20. PubMed ID: 24212468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microencapsulation of protein drugs for drug delivery: strategy, preparation, and applications.
    Ma G
    J Control Release; 2014 Nov; 193():324-40. PubMed ID: 25218676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The preparation and characterization of anti-VEGFR2 conjugated, paclitaxel-loaded PLLA or PLGA microspheres for the systemic targeting of human prostate tumors.
    Lu J; Jackson JK; Gleave ME; Burt HM
    Cancer Chemother Pharmacol; 2008 May; 61(6):997-1005. PubMed ID: 17701176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroPET and autoradiographic imaging of breast cancer alpha v-integrin expression using 18F- and 64Cu-labeled RGD peptide.
    Chen X; Park R; Tohme M; Shahinian AH; Bading JR; Conti PS
    Bioconjug Chem; 2004; 15(1):41-9. PubMed ID: 14733582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, characterization and in vitro and in vivo investigation of C₃F₈-filled poly(lactic-co-glycolic acid) nanoparticles as an ultrasound contrast agent.
    Wang CW; Yang SP; Hu H; Du J; Li FH
    Mol Med Rep; 2015 Mar; 11(3):1885-90. PubMed ID: 25394467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma sterilization of poly lactic acid ultrasound contrast agents: surface modification and implications for drug delivery.
    Eisenbrey JR; Hsu J; Wheatley MA
    Ultrasound Med Biol; 2009 Nov; 35(11):1854-62. PubMed ID: 19766380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic RGD peptide-conjugated polyplex micelles as a targetable gene delivery system directed to cells possessing alphavbeta3 and alphavbeta5 integrins.
    Oba M; Fukushima S; Kanayama N; Aoyagi K; Nishiyama N; Koyama H; Kataoka K
    Bioconjug Chem; 2007; 18(5):1415-23. PubMed ID: 17595054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porous polymer scaffolds surface-modified with arginine-glycine-aspartic acid enhance bone cell attachment and differentiation in vitro.
    Hu Y; Winn SR; Krajbich I; Hollinger JO
    J Biomed Mater Res A; 2003 Mar; 64(3):583-90. PubMed ID: 12579573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of in vitro and in vivo acoustic response of a novel 50:50 PLGA contrast agent.
    Wheatley MA; Forsberg F; Oum K; Ro R; El-Sherif D
    Ultrasonics; 2006 Nov; 44(4):360-7. PubMed ID: 16730047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the alpha(v)beta3 and alpha(v)beta5 integrins.
    Sung V; Stubbs JT; Fisher L; Aaron AD; Thompson EW
    J Cell Physiol; 1998 Sep; 176(3):482-94. PubMed ID: 9699501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.